Topic
rsv
1 stories related to this topic, newest first.
uctoday.comworld71 days ago
Moderna's mRESVIA Faces Challenges in RSV Vaccine Market
A Seeking Alpha analysis reported that Moderna's mRESVIA RSV vaccine has struggled to gain market share against established competitors in 2026. Pfizer and GSK secured early advantages through supply chain and contract arrangements following their first-to-market launches.
SE